Technology area: Biotechnology & Pharmaceuticals
11 pending office actions • 10 art units • 10 examiners • 0 of 11 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Uti Limited Partnership has 11 pending office actions in Biotechnology & Pharmaceuticals. The matters span 10 distinct examiners and 10 distinct art units, indicating a widely distributed prosecution docket with only limited overlap among examiner and art-unit assignments. This structure calls for disciplined matter tracking, deadline control, and response preparation tailored to individual examination settings.
DIBRINO, MARIANNE is the busiest examiner, with 2 pending actions. That assignment is the only identified examiner concentration above a single matter in the supplied data. The two matters before that examiner may support coordinated review, while the remaining docket requires separately managed prosecution strategies.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (18%) |
| §103 only | 2 (18%) |
| §112 only | 1 (9%) |
| Multi-statute (no §101) | 6 (55%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DIBRINO, MARIANNE | 2 | 42.8% | +42.2% |
| MOORE, WHITNEY | 1 | 88.2% | +10.1% |
| VU, QUYNH-NHU HOANG | 1 | 68.6% | +27.3% |
| HAILEY, PATRICIA L | 1 | 88.2% | +10.0% |
| GONZALEZ, LUISALBERTO | 1 | 59.7% | +46.3% |
| WITHERSPOON, SIKARL A | 1 | 86.3% | -20.1% |
| JONES, KOLTON ED | 1 | — | — |
| JOHNSON, CHRISTOPHER LINDSAY | 1 | 48.6% | +78.3% |
| WOITACH, JOSEPH T | 1 | 49.5% | +27.4% |
| SABILA, MERCY HELLEN | 1 | 57.5% | +45.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18290692 | METAL ORGANIC FRAMEWORK FILM AND METHOD OF MAKING | WITHERSPOON, SIKARL A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18026397 | METHODS OF TREATING AND/OR PREVENTING ALZHEIMER’S DISEASE WITH R-CARVEDILOL | JOHNSON, CHRISTOPHER LINDSAY | 66d overdue |
| 18744298 | SYSTEM AND METHOD FOR GLOBAL REAL-TIME KINEMATIC PRECISE POSITIONING | MOORE, WHITNEY | — |
| 18701047 | MICRONEEDLE AND ARRAY AND METHOD OF FABRICATING SAME | VU, QUYNH-NHU HOANG | — |
| 18691764 | SORBENTS AND METHODS FOR CARBON CAPTURE VIA CALCIUM LOOPING | HAILEY, PATRICIA L | — |
| 18288239 | ULTRA-STRONG HYDROGEL FIBERS | JONES, KOLTON ED | — |
| 18048339 | METHODS FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERES | DIBRINO, MARIANNE | — |
| 17661873 | METHODS AND COMPOSITIONS FOR SUSTAINED IMMUNOTHERAPY | DIBRINO, MARIANNE | — |
| 17715796 | SYSTEMS AND METHODS FOR PREDICTING CARDIOTOXICITY OF MOLECULAR PARAMETERS OF A COMPOUND BASED ON MACHINE LEARNING ALGORITHMS | WOITACH, JOSEPH T | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18026397 | METHODS OF TREATING AND/OR PREVENTING ALZHEIMER’S DISEASE WITH R-CARVEDILOL | JOHNSON, CHRISTOPHER LINDSAY | 66d overdue |
| 18581095 | Halogenated Xanthenes as Vaccine Adjuvants | GONZALEZ, LUISALBERTO | 19d overdue |
| 17532578 | NANOPARTICLES COMPRISING NON-CLASSICAL MHC AND USES THEREOF | SABILA, MERCY HELLEN | 19d overdue |
| 18744298 | SYSTEM AND METHOD FOR GLOBAL REAL-TIME KINEMATIC PRECISE POSITIONING | MOORE, WHITNEY | — |
| 18701047 | MICRONEEDLE AND ARRAY AND METHOD OF FABRICATING SAME | VU, QUYNH-NHU HOANG | — |
| 18691764 | SORBENTS AND METHODS FOR CARBON CAPTURE VIA CALCIUM LOOPING | HAILEY, PATRICIA L | — |
| 18048339 | METHODS FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERES | DIBRINO, MARIANNE | — |
| 17661873 | METHODS AND COMPOSITIONS FOR SUSTAINED IMMUNOTHERAPY | DIBRINO, MARIANNE | — |
| Art Unit | Apps |
|---|---|
| 1641 | 2 |
| 3646 | 1 |
| 3783 | 1 |
| 1732 | 1 |
| 1624 | 1 |
| 1692 | 1 |
| 1763 | 1 |
| 1691 | 1 |
| 1687 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18744298 | SYSTEM AND METHOD FOR GLOBAL REAL-TIME KINEMATIC PRECISE POSITIONING | MOORE, WHITNEY | 3646 | §101§102§103 | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18701047 | MICRONEEDLE AND ARRAY AND METHOD OF FABRICATING SAME | VU, QUYNH-NHU HOANG | 3783 | §102§103§112 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18691764 | SORBENTS AND METHODS FOR CARBON CAPTURE VIA CALCIUM LOOPING | HAILEY, PATRICIA L | 1732 | §102§112 | Non-Final OA | — | Pending | Mar 13, 2024 |
| 18581095 | Halogenated Xanthenes as Vaccine Adjuvants | GONZALEZ, LUISALBERTO | 1624 | §112 | Non-Final OA | 19d overdue | Pending | Feb 19, 2024 |
| 18290692 | METAL ORGANIC FRAMEWORK FILM AND METHOD OF MAKING | WITHERSPOON, SIKARL A | 1692 | §103 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18288239 | ULTRA-STRONG HYDROGEL FIBERS | JONES, KOLTON ED | 1763 | §103§112 | Non-Final OA | — | Pending | Oct 25, 2023 |
| 18026397 | METHODS OF TREATING AND/OR PREVENTING ALZHEIMER’S DISEASE WITH R-CARVEDILOL | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §102§103§112 | Non-Final OA | 66d overdue | Pending | Mar 15, 2023 |
| 18048339 | METHODS FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERES | DIBRINO, MARIANNE | 1641 | §103§112 | Final Rejection | — | Pending | Oct 20, 2022 |
| 17661873 | METHODS AND COMPOSITIONS FOR SUSTAINED IMMUNOTHERAPY | DIBRINO, MARIANNE | 1641 | §103§112 | Final Rejection | — | Pending | May 03, 2022 |
| 17715796 | SYSTEMS AND METHODS FOR PREDICTING CARDIOTOXICITY OF MOLECULAR PARAMETERS OF A COMPOUND BASED ON MACHINE LEARNING ALGORITHMS | WOITACH, JOSEPH T | 1687 | §101§103 | Non-Final OA | — | Pending | Apr 07, 2022 |
| 17532578 | NANOPARTICLES COMPRISING NON-CLASSICAL MHC AND USES THEREOF | SABILA, MERCY HELLEN | 1654 | §103 | Final Rejection | 19d overdue | Pending | Nov 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUti Limited Partnership has 11 pending office actions as of October 2026, spread across 10 art units and 10 examiners.
Marianne Dibrino has the most, with 2 of Uti Limited Partnership's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
